SCHEMBL24656108

SCHEMBL24656108

CC(C)(C)c1cnc2cc(CC(C)(C)c3ccc4ncccc4n3)cnc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.36
KDR P35968 1/20 0.33
TGFBR1 P36897 1/20 0.33
METAP2 P50579 1/20 0.33
TACR2 P21452 1/20 0.32
HRH2 P25021 1/20 0.32
GNRHR P30968 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
OPRK1 P41145 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
TRPV1 Q8NER1 2/20 0.32
OGA O60502 2/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
KDM4E B2RXH2 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25515395 0.81 GNRHR (0.35) PDE10AMETAP2TACR2HRH2GNRHR
SCHEMBL10243492 0.80 OGA (0.41) PDE10AKDRMETAP2TRPV1OGA
SCHEMBL26832115 0.76 PDE10A (0.35) PDE10AMETAP2TACR2HRH2GNRHR
SCHEMBL24176501 0.75 OGA (0.41) OGAMEN1KMT2AKDM4ECYP1A2
SCHEMBL20932780 0.73 ALDH1A1 (0.39) PDE10AMETAP2GNRHRTRPV1KDM4E
SCHEMBL9928477 0.72 ALDH1A1 (0.46) TGFBR1KDM4ECYP3A4ATMPOLB
SCHEMBL21497380 0.72 GNRHR (0.41) PDE10AGNRHRTRPV1KDM4EATM
SCHEMBL22078500 0.71 ALDH1A1 (0.35) PDE10AKDM4ECYP3A4ATMPOLB
SCHEMBL23190476 0.71 ALDH1A1 (0.40) PDE10AGNRHRKDM4EATMPOLB
SCHEMBL12524759 0.71 OGA (0.38) PDE10AOGAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP PDE10A 594/4885KDR 2013/4885TGFBR1 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.